Beginning Cash: The amount of cash reported by the company on its previous statement.
Klotho Neurosciences, Inc. (KLTO) had Beginning Cash of $0.00M for the most recently reported fiscal year, ending 2024-12-31.
Income Statement Financials | |
-- |
|
$-6.15M |
|
-- |
|
-- |
|
$5.54M |
|
$-5.54M |
|
$-0.61M |
|
$-6.15M |
|
$-6.15M |
|
$-6.15M |
|
$-6.15M |
|
$-6.15M |
|
$-6.15M |
|
$-5.54M |
|
$-5.53M |
|
19.25M |
|
19.25M |
|
$-0.32 |
|
$-0.32 |
|
Balance Sheet Financials | |
$0.16M |
|
-- |
|
$2.30M |
|
$2.46M |
|
$1.25M |
|
-- |
|
$0.02M |
|
$1.27M |
|
$1.19M |
|
$-1.11M |
|
$1.19M |
|
27.08M |
|
Cash Flow Statement Financials | |
$-2.95M |
|
$-0.12M |
|
$3.13M |
|
Beginning Cash |
$0.00M |
$0.06M |
|
$0.06M |
|
$2.65M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
0.13 |
|
-- |
|
-- |
|
-- |
|
0.23 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.95M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-518.87% |
|
551.99% |
|
-250.28% |
|
-518.87% |
|
$0.04 |
|
$-0.15 |
|
$-0.15 |